XML 33 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies
12 Months Ended
May 31, 2018
Commitments and Contingencies  
Commitments and Contingencies

 

10. Commitments and Contingencies

        On October 3, 2003, we entered into a sale-leaseback transaction whereby we sold and leased back a facility located in Garden City, New York. The lease is classified as an operating lease. Net proceeds from the sale of the facility were $14.0 million and the cost and related accumulated depreciation of the facility of $9.5 million and $4.6 million, respectively, were removed from the Consolidated Balance Sheet at the time of sale. The gain realized on the sale of $9.1 million has been deferred and is being amortized over the 20-year lease term. As of May 31, 2018 and 2017, the unamortized balance of the deferred gain was approximately $2.5 million and $2.9 million, respectively, and is included in Other liabilities and deferred income on the Consolidated Balance Sheet.

        In addition to the leases described above, we lease other facilities and equipment under agreements that are classified as operating leases that expire at various dates through 2034. Future minimum payments under all operating leases at May 31, 2018 are as follows:

                                                                                                                                                                                    

2019

 

$

17.5

 

2020

 

 

16.3

 

2021

 

 

13.0

 

2022

 

 

10.8

 

2023

 

 

10.0

 

2024 and thereafter

 

 

27.2

 

        Rental expense for facilities and equipment during fiscal years 2018, 2017, and 2016 was $23.5 million, $22.9 million, and $21.3 million, respectively.

        We enter into purchase obligations which arise in the ordinary course of business and represent a binding commitment to acquire inventory, including raw materials, parts and components, as well as equipment to support the operations of our business. The aggregate amount of purchase obligations due in each of the next five fiscal years is $203.4 million in 2019, $43.8 million in 2020, $6.0 million in 2021, none in 2022 and none in 2023.

        We routinely issue letters of credit and performance bonds in the ordinary course of our business. These instruments are typically issued in conjunction with insurance contracts or other business requirements. The total of these instruments outstanding at May 31, 2018 was approximately $16.7 million.

        We are involved in various claims and legal actions, including environmental matters, arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our consolidated financial condition or results of operations.